Evidence rocks in long-term care, but does it roll?
This article reviews the problems with the implementation of evidence-based care in long-term care. It highlights the fact that many common practices are incompatible with evidence and that available evidence, including evidence about inadvisable and ineffective treatments, is often not followed. Often, there is a tendency to follow recommendations for younger persons (for example, the management of hypertension and elevated cholesterol), or to use questionable interventions (for example, choices for treating constipation). In many cases, the treatments used have only marginal efficacy and increased potential for side effects. This article makes recommendations for improving the approach to evidence-based care in long-term care and strongly urges the FDA to require drug studies in nursing homes.
Levenson
Steven A
SA
Division of Geriatric Medicine, Saint Louis University School of Medicine, St Louis, MO 63104, USA.
Morley
John E
JE
D002908:Chronic Disease / Q000628:therapy*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006707:Homes for the Aged; D006801:Humans; D006937:Hypercholesterolemia / Q000628:therapy; D006973:Hypertension / Q000628:therapy; D008134:Long-Term Care; D009735:Nursing Homes